Co-Authors
This is a "connection" page, showing publications co-authored by Stanley Perlman and Jose Regla-Nava.
Connection Strength
0.441
-
Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. J Virol. 2015 Apr; 89(7):3870-87.
Score: 0.153
-
Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein. J Virol. 2013 Jun; 87(12):6551-9.
Score: 0.135
-
Role of Severe Acute Respiratory Syndrome Coronavirus Viroporins E, 3a, and 8a in Replication and Pathogenesis. mBio. 2018 05 22; 9(3).
Score: 0.048
-
Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine. PLoS Pathog. 2015 Oct; 11(10):e1005215.
Score: 0.040
-
Inhibition of NF-?B-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol. 2014 Jan; 88(2):913-24.
Score: 0.035
-
Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog. 2011 Oct; 7(10):e1002315.
Score: 0.030